Funobactam

福诺巴坦

Report date: 2025/12/31 13:42:31
NME

Base Information

Drug NameFunobactam
Drug Alias NameXNW-4107XNW4107
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBeta Lactamase inhibitors
TargetsBeta Lactamase
Therapy Area/IndicationsHospital-acquired pneumoniaCommunity-acquired bacterial pneumoniaPyelonephritis +[7] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesFranceIsrael +[5] 
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesSinovent Pty Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesEvopoint Biosciences Co Ltd
Inactive CompaniesN/A
Active IndicationsHospital-acquired pneumoniaCommunity-acquired bacterial pneumoniaPyelonephritis +[7] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksDrugBank